Medindia LOGIN REGISTER
Medindia
Advertisement

Drug Combo Better Than Individual Medications for Treating Chronic Pain

by VR Sreeraman on October 3, 2009 at 2:28 PM
 Drug Combo Better Than Individual Medications for Treating Chronic Pain

A combination of two commonly prescribed drugs offers a much more effective treatment for people with debilitating neuropathic pain than if they take either of the medications individually, according to a study by Queen's University researchers.

When given both an anti-seizure drug (gabapentin) and an antidepressant (nortriptyline), patients suffering from neuropathic pain caused by nerve damage or disease experienced less pain than when they took one or the other individually, reports Dr. Ian Gilron.

Advertisement

"It was also exciting to discover the effect of this combination on sleep interference," added Gilron.

He pointed out that people rated sleep interference with the combined drugs as 1.0 on a scale of 10, compared to 2.2 when they took each drug individually.
Advertisement

"That's a very important issue for this group of patients, whose debilitating, unrelenting pain often interferes with normal sleep," he said.

This is the first time that the researchers have found a drug combination that also helps patients sleep better.

Gilron says that it is important to understand how drugs interact, since 45 per cent of Canadians being treated for neuropathic pain take two or more pain drugs.

There may also be safety issues.

"We need more evidence from carefully conducted trials in support of each particular combination, and let the doctors and patients know about such results," said Gilron.

The methodology behind the treatment could also be applied to the study of other chronic conditions such as cancer-related pain, spinal disk disease, and the pain experienced after chemotherapy and mastectomies, said Gilron.

The study's findings have been published in The Lancet.

Source: ANI
SRM
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Drug News

Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
Anti-cancer Drug Navitoclax Help Treat Lower Back Pain
The reduction of these senescent osteoclasts, possibly through the utilization of current medications, could present a novel approach in managing lower back pain.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Drug Combo Better Than Individual Medications for Treating Chronic Pain Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests